MedTrace Logo

Vaginal Estrogen for the Treatment of Faecal Incontinence in Women

NCT00307775 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2012-05-01

No results posted yet for this study

Summary

This study will address the following questions:

* Does the use of oestrogen inserted vaginally with an applicator, help with the symptoms of faecal (bowel) incontinence in women who are past the age of menopause?
* Do women find it easy to use?
* Is the treatment safe for the womb lining?
* Is there any systemic absorption of the treatment?

Conditions

  • Fecal Incontinence

Interventions

DRUG

oestradiol

Sponsors & Collaborators

  • London North West Healthcare NHS Trust

    lead OTHER

Principal Investigators

  • Kathy Abernethy, RN ENB · London North West Healthcare NHS Trust

  • Joan Pitkin, MB BS BSc FRCS FRCOG · London North West Healthcare NHS Trust

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00307775 on ClinicalTrials.gov